Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive, Peripheral × Ipilimumab × 1 year × Clear all

Sponsor

Conditions

Melanoma 65 Carcinoma, Renal Cell 32 Carcinoma, Non-Small-Cell Lung 31 Neoplasm Metastasis 22 Colorectal Neoplasms 13 Carcinoma, Hepatocellular 13 Brain Neoplasms 13 Skin Neoplasms 11 Uveal Melanoma 10 Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Lung Neoplasms 9 Urinary Bladder Neoplasms 8 Prostatic Neoplasms 8 Ovarian Neoplasms 8 Kidney Neoplasms 8 Sarcoma 7 Carcinoma, Transitional Cell 7 Pancreatic Neoplasms 6 Glioblastoma 6 Colonic Neoplasms 6 Carcinoma, Merkel Cell 6 Small Cell Lung Carcinoma 5 Recurrence 5 Mesothelioma, Malignant 5 Mesothelioma 5 Carcinoma, Neuroendocrine 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Myelodysplastic Syndromes 4

Interventions

X-Rays 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 Magnetic Resonance Spectroscopy 5 Specimen Handling 4 Biopsy 4 ulixertinib 2 tipifarnib 2 selpercatinib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Melphalan 2 Etoposide 2 trioctyl phosphine oxide 1 thymoglobulin 1 temsirolimus 1 tazemetostat 1 talazoparib 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 fludarabine phosphate 1 amino-acid, glucose, and electrolyte solution 1 Vincristine 1 Vemurafenib 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡